Online inquiry

IVTScrip™ mRNA-Human ALK6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16021MR)

This product GTTS-WK16021MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ALK6 protein. This product can be used in Mesenchymal stem cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001203.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 658
UniProt ID O00238
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ALK6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16021MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK2315MR IVTScrip™ mRNA-Human PKC-alpha, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA PKC-alpha
GTTS-WK2401MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK2772MR IVTScrip™ mRNA-Human CD292, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA CD292
GTTS-WK14453MR IVTScrip™ mRNA-Human AK8, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA AK8
GTTS-WK13031MR IVTScrip™ mRNA-Human ACO1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACO1
GTTS-WK13683MR IVTScrip™ mRNA-Human ACYP2, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACYP2
GTTS-WK25120MR IVTScrip™ mRNA-Human ASNS, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASNS
GTTS-WK13860MR IVTScrip™ mRNA-Human ABHD12, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ABHD12
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW